We have recently described two yeast strains that are mutated in the MRF1 gene encoding the mitochondrial release factor mRF-1. Both mutants provoke genespecific defects in mitochondrial translational termination. In the present study we report the cloning, sequencing, as well as an analysis of residual activities of both mutant mrf1 alleles. Each allele specifies a different single amino acid substitution located one amino acid apart. The amino acid changes do not affect the level or cellular localization of the mutant proteins, since equal amounts of wild type and mutant mRF-1 were detected in the mitochondrial compartment. Overexpression of the mutant alleles in wild type and mrf1 mutant yeast strains produces a phenotype consistent with a reduced affinity of the mutant release factors for the ribosome, indicating that the mutations map in a release factor domain involved in ribosome binding. We also demonstrate that nonsense suppression caused by a mutation in the mitochondrial homolog of the E.coli small ribosomal protein S4 can be reversed by a slight over-expression of the MRF1 gene.
INTRODUCTION
The final step of polypeptide chain synthesis involves the hydrolysis of peptidyl-tRNA in response to the appearance of a stop codon at the ribosomal decoding site. This termination event is mediated by peptide chain release factors (RFs), proteins that bind specifically to ribosomes that have encountered an inframe stop codon and that interact with the peptidyl transferase centre to achieve hydrolysis of the nascent protein (reviewed in 1, 2). In bacteria three RFs are involved in termination at three different stop codons: RF-1 mediates termination at UAG codons, RF-2 at UGA codons, while both RF-1 and RF-2 are able to catalyze UAA-dependent termination. RF-3 stimulates the activity of the other RFs but lacks codon-specificity (3) . The genes encoding RF-1 and RF-2 have been cloned and sequenced for Escherichia coli and Salmonella typhimurium (for review see 4). Recently we identified a gene which in all probability codes for the Bacillus subtilis RF-2 (5) .
We have reported the cloning and sequencing of the first gene that codes for an organellar release factor, the MRF1 gene of the yeast Saccharomyces cerevisiae encoding the mitochondrial release factor mRF-1 (6) . mRF-1 resembles bacterial RF-1 and RF-2 and is in all probability an RF-1 homolog, since UGA codes for tryptophan in yeast mitochondria. The MRF1 gene was cloned by genetic complementation of two respiratory deficient yeast mutants. Analysis of the mitochondrial translation products synthesized in these mutants revealed strongly diminished amounts of cytochrome c oxidase subunits 1 and 2, while moderately reduced levels were found for several other products (6 and M.Rep, unpublished results).
In the present study we cloned and sequenced the mrfl alleles of both mutants in order to identify the amino acid changes responsible for the gene-specific defects. Both alleles turned out to specify single amino acid changes that map only one residue apart in release factor domain n (5). The role of the mutated amino acids in release factor function will be discussed in light of the activities displayed by both mutant alleles when overexpressed in wild type, mrfl mutant and mitochondrial nonsense suppressor strains.
MATERIALS AND METHODS Strains and media
The Saccharomyces cerevisiae strains used in this study are listed in Table 1 . MJV1 and MB23-73A are isomitochondrial strains that contain a nonsense mutation (V25) in the mitochondrial COX2 gene. In MJV1 the mutation is partially suppressed by a mitochondrial point mutation (MSU1) in the 15S ribosomal RNA. We have shown before that the suppressive effect of MSU1 can be reversed by over-expression of the MRF1 gene (6) . In strain MB23-73A the nonsense mutation is partially suppressed by a mutation in a nuclear gene, NAM9 (11) . Strain MJV5 is a spontaneous Iys2 mutant of MB23-73A isolated on plates containing a-aminoadipic acid as described by Chattoo and Sherman (12) .
The mitochondrial genomes of MJV1 and MB23-73A were originally derived from wild type strain 777-3A (13) . Isonuclear wild type and mrfl mutant strains containing 777-3A mitochondria were constructed as follows. D273UK was derived from D273-10B/A1 in two steps: first a spontaneous Iys2 mutant was isolated as described above, next a spontaneous ura3 mutant was isolated on plates containing 5-fluoro-orotic acid as described by Boeke et al. (14) . The nature of the spontaneous mutations was confirmed by crosses to strains with established Iys2 and ura3 markers. A derivative lacking mitochondrial DNA (D273UK Q °) was obtained by overnight growth in liquid YPD medium containing 20 /ig ethidium bromide per ml (15) . Strain EY93(777) was constructed by cytoduction (16) of 777-3A mitochondria into EY93 Q°. Next, D273UK(777) was constructed by cytoduction of EY93(777) mitochondria into D273UK Q °. An isonuclear and isomitochondrial mrfl mutant, Dl(777), was constructed by cytoduction of EY93(777) mitochondria in Dl g°, a strain constructed by replacing the MRF1 gene of D273UK e° for a copy of the mrfl-1 allele by the pop-in/pop-out replacement technique (17) .
The following media were used for propagation of yeast: YPD (2% glucose, 2% peptone, 1% yeast extract); YPEG (2% glycerol, 2% ethanol, 2% peptone, 1% yeast extract); YPLactate (0.1% glucose, 1.5% lactic acid, 2% sodium lactate, 8 mM MgSO 4 , 45 mM (NR^HPO^ 0.5% yeast extract); WO (2% glucose, 0.67% yeast nitrogen base without amino acids (Difco)); WOG (as WO but 2% glycerol instead of glucose); WOEG (as WOG, contains also 2% ethanol). Where required, media were supplemented with nutritional requirements (20 /ig/ml). Solid media contained 2% agar.
Cloning of MRF1 alleles Total DNA of strains D273-10B/A1, E372, W303-1A and Wl was isolated as described by Hoffman and Winston (18) . 100 ng DNA was used to amplify the MRF1 alleles by PCR using Vent DNA polymerase as described by the manufacturer (New England Biolabs). The primers used are MRF1/OL1: 5'-CTT-CAACTCTCTTGCGCACTGG-3' (positions 737-758 in 6) and MRF1 /OL6: 5 '-ataggtacCTGAACTGTTGAGGCGGTAC-3'. The nucleotides in MRF1/OL6 shown in uppercase are complementary to nucleotides 2532-2551 in (6), the nucleotides in lowercase create a Kpnl restriction site at the 5'-end of the amplified fragment. Amplification schedule: 2' 94°C; 15 times 1' 94°C, 2' at 58°C, 3' 75°C; 10 times 1' 94°C, 2' at 58°C, 4' 75°C. Amplified fragments were purified, digested with Kpnl and cloned in the vector YEplacl81 (19) restricted with BamHl, blunted with the Klenow fragment of E.coli DNA polymerase and digested with Kpnl, yielding the following constructs: pD273/Sl, pE372/Sl, pW3O3/S2 respectively pWl/Sl. Restriction analysis of these constructs revealed that the correct inserts were present in the unforeseen orientation and that the expected Kpnl site was absent. Sequence analysis of the plasmidinsert junction revealed that primer MRF1/OL6 lacked a varying number of 5'-terminal nucleotides (7 nucleotides in both pD273/Sl and pWl/Sl, 9 nucleotides in pW3O3/S2 and 11 nucleotides in pE372/Sl) including (major part of) the Kpnl site, suggesting the presence of a high percentage of incomplete oligonucleotides in the primer batch used.
Plasmids containing the LYS2 gene were constructed by cloning a 4.9 kb HindfR-Xbal fragment derived from plasmid pDP6 (20) containing the LYS2 gene into pD273/Sl, pE372/Sl, pW303/S2 and pWl/Sl restricted with HindSR and Xbal, yielding pD273/SKl, pE372/SKl, pW303/SK2 respectively pWl/SKl. Plasmids pG174/Cl, pG174/CKl, pG174/S17, pG174/SK17 and YEpLKl have been described previously (6) .
Construction of MRFl/c-myc fusion genes For the construction of MRFl/c-myc fusion genes we made use of the vectors YEpmycl81 and YCpmyclll that contain a synthetic c-myc epitope cloned in the polylinker (21, Figure 3 ). Plasmid pG174/C3-2 consists of a 3.3 kb Fspl fragment derived from pG174/Cl cloned in the Smal site of YCplaclll. The orientation of die insert is such that the MRF1 gene runs from the Hmdm site in the polylinker. pG174/C3-2 was used as template in a PCR reaction to amplify a DNA fragment containing Figure 3 ). The presence of the Smal site as well as the nucleotide sequence of the junction and the epitope were checked for both constructs. In order to tag mutant mRF-1 with the c-myc epitope a 1.0 kb Xhol-BcH internal fragment (6) containing the mutation was isolated from pE372/Sl as well as pWl/Sl and cloned into YEpMMlO digested with the same enzymes, thus generating plasmid YEpMMll containing the mrfl-1 allele derived from pE372/Sl and plasmid YEpMM12 containing the mrfl-2 allele derived from pWl/Sl.
DNA sequence analysis
The DNA sequence of the cloned MRFl alleles was determined according to the method of Sanger et al. (22) . Oligonucleotides used as primers include MRF1/OL1, MRF1/OL5 and MRF1/OL6 described above, as well as MRF1/OL2: 5'-G-AGCGTTAATAGTGCG-3' (nucleotides 1062-1077 in (6), MRF1/OL3: 5'-GCTAAATTATCAGCGC-3' (nucleotides 1405-1420), MRF1/OL4: 5'-AGGTGGCATTGAAGCC-3' (nucleotides 1638-1653), and MRF1/HMO 5'-GAGTCTGTCGTgTTaACATGTTGACC-3' (complementary to nucleotides 2005-2030, lowercase nucleotides mismatch with wild type MRFl and can be used to introduce an Hpal restriction site by site-directed mutagenesis).
Western blot analysis
Yeast strains transformed with one of the various MRFl constructs were grown until stationary phase on selective WO medium (W303-1A) or YPLactate (YP102). Total cell lysates were prepared as follows: 15 mg cells suspended in 500 jil 5% trichloroacetic acid (TCA) were broken by vigorous vortexing for 10 min in the presence of 0.5 volume of glass beads (0 0.45 mm). After collection of the cell lysates the beads were washed with 500 /d 5% TCA. Precipitated proteins were pelleted by centrifugation for 10 min at 12,000 rpm and resuspended in Laemmli sample buffer (23) . Cytoplasmic and mitochondrial fractions were prepared by lysis of spheroplasted cells in 0.6 M mannitol, 20 mM Tris-Cl pH 6.7, 0.5 mM EDTA, by treatment with a Dounce homogenizer. Unbroken cells and cell-debris were removed by a low-speed spin (4,000 rpm for 5 min). Mitochondria were pelleted by a high-speed spin (12,000 rpm for 10 min) and lysed in sample buffer (mitochondrial fraction). 0.1 volume 50% TCA was added to the supernatant in order to precipitate cytosolic proteins. The precipitated proteins were collected by centrifugation (10 min at 12,000 rpm) and suspended in sample buffer (cytosolic fraction). For Western blotting, amounts of each mitochondrial protein sample were adjusted acording to the abundance of the protein being detected: 40 mg for hexokinase, 60 mg for citrate synthase and 120 mg for mRF-1-c-myc. The amounts of the cytosolic fraction applied were such that in each case the ratio of sample-to total cellular protein was maintained constant, thus allowing direct comparison of the relative abundance of the detected proteins in the two fractions. Blotting was performed essentially as described in the Promega Protocols and Applications Guide, second edition, 1991. A monoclonal antibody used to detect the human c-myc epitope was obtained from ICI, Cambridge Research Biochemicals (clone 9E10). The polyclonal antiserum raised against yeast mitochondrial citrate synthetase was a gift from Dr G.Schatz (Basel).
Miscellaneous
Standard techniques were used for manipulation of DNA, transformation of E.coli, Southern blotting (24) and transformation of yeast cells (25) .
RESULTS

Cloning and sequence analysis of two mutant mrfl alleles
We have recently described two yeast strains (E372 and Wl) that are mutated in the MRFl gene encoding the mitochondrial release factor mRF-1 (5, 26) . In order to characterize these mutants in more detail, we cloned the mrfl alleles of these mutants {mrfl-1 for E372 and mrfl-2 for Wl) and their respective parents D273-10B/A1 and W3O3-1A. A detailed description of the PCRmediated cloning procedure is presented in the Materials and Methods section. The N-terminal PCR primer MRFl/OLl starts 413 nucleotides upstream of the predicted initiation codon in the C-terminal region of ORF2, an open reading frame ending 313 nucleotides upstream of the MRF1 gene. The nucleotide sequence included in the amplified DNA fragment contains all determinants essential for MRF1 expression, since a low copy number plasmid containing the MRF1 gene and only 202 nucleotides of the upstream region complements mrfl mutants as well as larger constructs (6) . The amplified wild type and mutant DNA fragments had a similar size of 1.8 kb (data not shown). Restriction analysis, however, revealed that the mrfl-1 allele lacks the only EcoN site in the MRF1 gene. Southern blotting of total DNA isolated from W3O3-1A, Wl, D273-10B/A1, E372 and E372/L6, a spore derived from E372 and containing the same mrfl allele as E372 (6) , confirmed the results obtained with the cloned alleles. The MRF1 locus of Wl was indistinguishable from that of W303-1A or D273-10B/A1, while E372 as well as E372/L6 lacked the EcoKl site in the MRF1 gene, indicating a mutation in this restriction site (data not shown).
The 1.8 kb DNA fragment bordered by the primers MRFl/OLl and MRF1/OL6 was sequenced completely for both mutant alleles whereas both wild type alleles were sequenced for about 40%, including the region containing the mutations. The sequencing revealed no differences between the various alleles and the previously obtained nucleotide sequence (6) apart from a different single nucleotide substitution in the coding region of each mutant allele (Figure 1 ). The mrfl-1 allele contains a G to A transition at position 1841 resulting in an arginine to lysine change of amino acid 231. The mrfl-2 allele contains a T instead of a C residue at position 1847 resulting in a proline to leucine change of amino acid 233. G-1841 is part of the £coRI recognition sequence GAATTC and its substitution in the mrfl-1 allele is in full agreement with the absence of this site as observed by restriction site analysis and Southern blotting. As Figure 2 shows, both mutant amino acids map very near each other in a region of high sequence similarity between mitochondrial and bacterial release factors. Since mRF-1 is in all probability an RF-1 type release factor (6), it is quite interesting that the only two RF-1 mutations that have been sequenced to date both map to the same region ( Figure 2 ). All four mutations are located within release factor domain n, previously proposed to interact with the interface sides of the ribosomal subunits in an area bordered by the base of the L7/L12 stalk and the peptidyl transferase centre on the large subunit and the opposing neck-region of the small subunit (5). 
Construction of epitope-tagged wild type and mutant mRF-1
The mutations found in mRF-1 may lower the intrinsic activity of the protein, however, they can also affect the availability of the protein by hampering its synthesis, by reducing its stability or by affecting its cellular localization. In order to compare amount and localisation of wild type and mutant mRF-1, an epitope sequence derived from human c-myc was fused to the C-terminus of these proteins as described in Materials and Methods. Figure 3 displays the nucleotide and amino acid sequence of the epitope as well as the MRFl/c-myc junction. In order to rule out possible deleterious effects of the epitope sequence on mRF-1 function, the epitope-containing constructs YCpMMlO (low copy, wild type MRF1), YEpMMlO (high copy, wild type MRF1), YEpMMll (high copy, mrfl-1) and YEpMM12 (high copy, mrfl-2) were transformed to mrfl mutant Wl and their complementation compared to that of the epitopelacking constructs pG174/Cl, pG174/S17, pE372/Sl and pWl/Sl respectively. All constructs that contain wild type mRF-1 complemented the glycerol-negative phenotype of Wl to the same extent (data not shown), indicating that they can be used to monitor the amount and subcellular localization of mRF-1. Only the multicopy suppression of the mrfl-1 allele (see below) is slightly reduced in Wl cells transformed with YEpMMll compared to pE372/Sl (data not shown). that the 50 kDa protein corresponds to mRF-1. First, the abundance of the 50 kDa band correlates well with the copy number of the transformed plasmid. Second, the estimated size of the protein is in good agreement with the size of 48.2 kDa predicted for the tagged mRF-1 (46.7 kDa for mRF-1, 6; 1.5 kDa for the c-myc epitope, Figure 3) . A definitive comparison between the apparent and predicted size of mRF-1 is complicated by the fact that the N-terminus of mRF-1 is probably cleavedoff during import into mitochondria (6) . In that case die 50 kDa protein should represent the processed form, as evidenced by its presence in the mitochondrial compartment.
Wild type and mutant mRF-1 are mitochondrial proteins
To establish the cellular localization of the mutant release factors encoded by the mrfl-1 and mrfl-2 allele, cytosolic and mitochondrial protein fractions were isolated from yeast cells containing a construct that over-expresses a mutant mrfl allele (YEpMMll or YEpMM12). As is evident from Figure 4B , probing of these lysates with anti-c-myc antiserum uncovered no differences when compared to lysates from cells over-expressing wild type mRF-1, thus demonstrating that the mutation present in each allele affects neither the abundance nor the cellular localization of the mutant proteins.
Residual activities of mutant mRF-1
The glycerol-negative phenotype of both mrfl mutants indicates that a single copy of each mutant mrfl allele produces insufficient mitochondrial release activity to support growth on nonfermentable carbon sources such as glycerol. However, since both mutants display a leaky mutant phenotype compared to the effects of complete inactivation of the MRF1 gene (6), it was interesting to ask whether the same alleles can support growth on glycerol when present in multiple copies per cell. In fact, the leaky phenotype demonstrates that both mutant release factors are able to catalyze translational termination, albeit with a reduced efficiency. In order to analyze the residual activities, the high copy number MRF1 constructs pD273/SKl, pE372/SKl and pWl/SKl were transformed to mrfl mutants Wl. As expected, the wild type MRF1 allele present in pD273/SKl fully complements the mutant phenotype ( Figure 5A ). In contrast, no complementation was observed upon introduction of pWl/SKl containing the mrfl-2 allele, whereas multiple copies of the mrfl-1 allele restore growth on glycerol of mutant Wl to near wild type levels (colonies are slightly smaller than those formed by cells containing wild type MRF1). These results indicate that, although both mutations map in the same release factor domain, only the mrfl-1 allele has a detectable residual activity in mutant Wl.
Over-expression of the mutant alleles in wild type strain W3O3-1A revealed no deleterious effects on growth on glycerol (data not shown). For the mrfl-1 allele this is not a surprise, since this allele restores the growth on glycerol of Wl almost completely, however, for the mrfl-2 allele it demonstrates that the over-expressed mutant release factor is unable to compete efficiently with wild type mRF-1 for ribosome binding, indicating a reduced affinity for the ribosome.
A third method to analyze the activity of mutant mRF-1 is the mitochondrial nonsense suppressor assay developed for the initial characterization of the MRF1 gene (6). Yeast strain MJV1 contains a point mutation (MSU1) in its mitochondrial small (15S) ribosomal RNA that suppresses an ochre mutation (V25) in the mitochondrial COX2 gene. The suppressor mutation allows a natural aminoacyl-tRNA to compete with mRF-1 resulting in readthrough at the ochre codon and slow growth on nonfermentable substrates. Increased mRF-1 levels reduce this suppression and growth. The sensitivity of the assay has been demonstrated by the fact that introduction of a centromeric plasmid (1-3 copies per cell) containing the MRFl gene strongly reduces growth on glycerol (6) . We transformed MJV1 with pD273/SKl, pE372/SKl and pWl/SKl respectively in order to determine whether high concentrations of mutant mRF-1 are able to reduce mitochondrial nonsense suppression. As shown in Figure 5B , over-expression of wild type mRF-1 completely abolished growth on glycerol as reported before. However, quite unexpectedly, neither mutant allele is able to reduce nonsense suppression. This raises a fascinating paradox for the activity of the mrfl-1 allele, since the same construct complements mutant Wl almost completely (cf. Figure 5A) .
Recently Boguta et al. characterized another suppressor strain (MB23-73A) that allows readthrough at nonsense mutation V25 in the COX2 gene resulting in slow growth on glycerol media (11) . This strain contains a mutation in a nuclear gene (NAM9) that encodes the yeast mitochondrial homolog of the E.coli small ribosomal subunit protein S4. In order to be able to transform MB23-73A with the various MRFl constructs containing the LYS2 gene as selection marker, a spontaneous tys2 mutant, MJV5, was isolated. Transformation of MJV5 with an intact MRFl gene on either a centromeric or a multicopy plasmid completely abolished the slow growth on glycerol. The complete absence of glycerol growth in the presence of die centromeric plasmid indicates that uiis assay is even more sensitive than the MSU1 -assay. However, as in the MSUl-assay, the introduction of multicopy plasmids containing an mrfl-1 or an mrfl-2 allele yielded no detectable reduction in growth on glycerol media (Figure 6 ).
The lack of residual activities of the mrfl-1 allele in both nonsense suppression strains could be an indication that the suppressor mutations present in the mitochondrial translation apparatus of these strains hamper residual mrfl-1 activity. To test for this possibility, we checked whether over-expression of the mrfl-1 allele also results in complementation of the glycerolnegative phenotype of an mrfl mutant with the same mitochondrial background as the nonsense suppressor strains. Wild type and mrfl mutant strains isomitochondrial to MJV1 and MJV5, but lacking nonsense mutation V25 as well as either nonsense suppressor mutation were therefore constructed as described in Materials and Methods. Transformation of wild type strain D273(777) with wild type (pG174/CKl and pD273/SKl) or mutant (pE372/SKl and pWl/SKl) MRFl constructs did not visibly affect the growth on glycerol media. As expected, the glycerol-negative phenotype of mutant D 1(777) was complemented by both wild type MRFl constructs and, as in Wl, no complementation was observed upon introduction of pWl/SKl containing the mrfl-2 allele. Unexpectedly, however, multiple copies of the mrfl-1 allele (pE372/SKl) restored glycerol growth of mutant D 1(777) only to a limited extent (about 5% of wild type as estimated from colony size, data not shown). The latter result clearly differs from the near full complementation observed in mutant Wl and it shows that even in the absence of a suppressor mutation the mitochondrial translation apparatus present in D 1(777) does not fully support the residual activity of the mutated release factor.
DISCUSSION
Yeast strains carrying an inactivated MRFl gene grow normally on fermentable carbon sources but lack mitochondrial respiration. The same gene reduces mitochondrial nonsense suppression in a dosage-dependent manner. Both observations have been important clues in establishing that mRF-1 functions in the mitochondrial compartment of the yeast cell (6) . In this study we have visualized mRF-1 by the attachment of a c-myc eptitope to its C-terminus. Fractionation of yeast cells expressing tagged wild type mRF-1 clearly confirmed that the protein is exclusively localized in mitochondria. Mitochondrial lysates isolated from yeast cells transformed with a low copy number MRFl/c-myc construct revealed a weak mRF-1 signal. Even though exact concentrations cannot be determined by the approach used, this result indicates that mRF-1 is present in low amounts in these organelles. This is in line with the low codon bias index (0.14; 27) of the MRFl gene and the low amount of MRFl transcripts present in yeast cells (H.J.Pel, unpublished results). Klein and Capecchi (28) estimated that there are about 500 molecules of RF-1 and 700 molecules of RF-2 per E.coli cell. The low abundance of release factors may be important for proper 'translation' of those stop codons that specify a translational pause, thus allowing alternative events like readthrough, frameshifting or specific amino acid incorporation, instead of termination of polypeptide chain synthesis (1 and references therein). In line with this, over-expression of RF-1 and RF-2 is deleterious to bacterial cells (29, 30) . In contrast, we have never observed any harmful effect of high mRF-1 levels in wild type yeast cells, suggesting that stop codon avoidance does not play a crucial role in mitochondrial gene expression.
Sequence analysis of the two mutant mrfl alleles has disclosed that each mrfl mutant contains a different single amino acid substitution in the same region of mRF-1. These substitutions have no effect on the availability of mRF-1 in mitochondria, since equal amounts of correctly processed wild type and mutant mRF-1 were detected. A deleterious effect on the biosynthesis or mitochondrial import of mRF-1 was also not expected, since the region upstream of the initiation codon and the presumed Nterminal mitochondrial targeting sequence are both unaffected. Taken together, we conclude that the defects described for the mrfl mutants can only be explained in terms of an altered intrinsic activity of the mutant release factor. The two mrfl mutants manifest these altered mRF-1 activities as an overall reduction in termination efficiency, as well as several more gene-specific defects in translational termination (6 and M.Rep, unpublished results). Since ochre codons are the only naturally occurring termination codons in yeast mitochondria, the specificity is most likely due to the sequence context of the relevant termination codons. It is quite remarkable that the only other mutations in RF-1 type RFs that have been sequenced to date (31) map close to the mRF-1 mutations identified in this study (Figure 2 ). These RF-1 mutations belong to two Salmonella typhimurium mutants that were isolated as suppressors of a UAG codon in a reporter lacZ gene. Both mutants grow indistinguishably from wild type strains, yet cause a 14 to 34-fold increase of readthrough at certain UAG codons (31) , suggesting that here too context effects could play a role. Context effects, however, yield little direct information on the nature of the defects exerted by the release factor mutations, since the sequences flanking termination codons influence not only the efficiency of termination, but also the readiness of termination avoiding processes like readthrough and frameshifting (32, 33) .
In order to investigate the functional consequences of the release factor mutations in more detail, we analyzed the effect of overexpression of the two mutant alleles in various yeast strains. Interestingly, this approach yielded a clear difference in the remaining activities of both alleles. Multiple copies of the mrfl-I allele, but not the mrfl-2 allele, complement the glycerol-negative phenotype of mutant Wl almost completely. Over-expression of the mutant alleles in a wild type strain had no deleterious effects on mitochondrial translation, as evidenced by normal growth on glycerol. For the mrfl-2 allele these results demonstrate that a large excess of its product fails to compete efficiently with wild type mRF-1. This lack of competition points to a primary defect in ribosome binding, since release factors unable to catalyze termination but active in ribosome binding are expected to have a dominant inhibitory effect on translation due to a stalling of ribosomes at stop codons (34) . The fact mat the amino acid substitutions specified by the mrfl-1 and the mrfl-2 allele map only one residue apart suggests that they confer a similar kind of defect. The near full complementation of mutant Wl by the mrfl-1 allele is not inconsistent with a primary defect in ribosome binding, since such a defect should be compensable by increasing the concentration of mutant protein. We therefore infer that the region affected in both mutants is important for ribosome binding. The finding that two S. typhimurium mutations map to the homologous region in RF-1, implies that this area is highly susceptible to the generation of subtle changes in the interaction between ribosomes and RF-1 type release factors. A comparison of currently available release factor sequences predicts a fivedomain structural model, in which the mutated release factor domain could interact with the ribosome at the entrance to the cleft between the two ribosomal subunits (5) .
In this study we show that low as well as high copy number plasmids containing the wild type MRF1 gene eliminate the stop codon readthrough provoked by a suppressor mutation in the mitoribosomal protein encoded by the NAM9 gene. This result implies that, in addition to the MSU1 assay, we have at our disposal a second nonsense suppressor assay to monitor mitochondrial release factor activity. Interestingly, current structural models of the E.coli ribosome predict the two suppressor mutations to be located in the same region of the small ribosomal subunit. The MSU1 mutation is located in the so-called 530-loop of 16S-like ribosomal RNAs (35) . The NAM9 protein represents the yeast mitochondrial counterpart of E.coli ribosomal protein S4 (11) . In E.coli ribosomes S4 is bound to the 'S4-junction', a 16S rRNA region that includes the stem of the 530-loop (36) . There are also striking similarities between the function of the 530-region and S4. Mutations in both entities can increase the translational error frequency, thus conferring a ribosomal ambiguity (ram) phenotype (37) . Moreover, both 530-loop and S4 are implicated in EF-Tu binding and it has been proposed that mutations in these components can cause a ram phenotype by altering the interaction between ribosome and EFTu (38) . For the present study it is of great interest that E.coli S4 also has been implicated in release factor binding (2, 39, 40) . It has indeed previously been shown that EF-Tu and RF-2 bind E.coli ribosomes in a mutually exclusive manner (41) . Interestingly, both MSU1 and NAM9 suppressors specifically suppress nonsense and not frameshift mutations (11, 42) , a fact which could indicate that they cause a primary effect on binding of release factor and not EF-Tu. It is conceivable that depending on the selection system used, mutants specifically affected in either release factor or EF-Tu binding can be obtained.
The over-expression of the mrfl-1 allele in the two mitochondrial nonsense suppressor strains yielded an unexpected paradox for the residual activity of this allele. In spite of near full complementation of mutant Wl, no activity was observed in either of the two nonsense suppressor assays. Both assays are sensitive indicators of release factor activity as demonstrated by the observation that introduction of a centromeric plasmid containing the MRF1 gene leads to a strongly reduced (MSU1 assay) or a complete absence {NAM9 assay) of growth on glycerol media. This paradox may suggest that the mutant release factor interacts more poorly with ribosomes that contain the MSU1 or NAM9 suppressor mutation than with wild type ribosomes. However, experiments to verify this hypothesis demonstrated that over-expression of the mrfl-1 allele only marginally complemented the glycerol-negative phenotype of an mrfl mutant, D 1(777), that contains a mitochondrial genome resembling that of the nonsense suppressor strains. This result indicates the existence of differences in the mitochondrial translation apparatus of D 1(777) compared to Wl that impede the residual activities of the mrfl-1 allele. Furthermore, it suggests that the same differences prevent the detection of residual release factor activity of the mrfl-1 allele in the nonsense suppression assays. A definitive answer concerning the role of the suppressor mutations in release factor binding can be obtained by studying the in vitro binding properties of suppressor ribosomes.
